I agree on the sale now, growth rates are slowing, FDA is a usual liberal slow down to capitalism with no quick answers to anything. Coming up on 2 years since the untitled letter. Collafix seems like bringing out something old that was locked in the basement as no new products can bring s pop to the business. If collafix was that great it wouldn't have been shelved for 4 years. The only ones who have the power and money to put up with multiple BLA's , patent lawsuits, oig investigations, FDA quagmires are large medical device or pharma companies, little mdxg with 475 employees and 200 million in sales is not going to scare anyone. Yes, I'm part of the dollar club and have no plans to sell, but if this is to remain a high growth company then they need to either announce more disruptive products or borrow a billion dollars and start making some buyouts of their own. Of course if operating Margins do exceed 25 percent in a couple of years a one time 10 percent dividend would heal some wounds. It is almost we are cursed because we are debt free and growing cash. Speculation runs higher when the companies have maybe one year of cash burn left and everyone is scared of the next secondary. Time to bring some fizz back to the town that is famous for soda.
And to think mdxg has traveled from under one dollar to nearly 13 and we haven't had "the" short squeeze yet. When that storm hits we will need spatulas to scrape the shorts off of the pavement, that day is coming soon. Earnings come out soon!
Been trading for over 30 years, I am biased with mdxg, with that said most chartist expect mdxg to pull back and test low 12's , market doesn't usually do what most want, wouldn't be surprised to see run keep going to cause most pain
Market, the Medtronic and Zimmer deal are sold under non Mdxg labels. After 2 years the ramp is slow, hopefully your Stryker deal will move faster.
I listened to most of Interview, Joe Kernan did some homework. Seemed to stay on wound care , bed sores and mentioned a few other areas but I did t hear anything regarding sports. Premarket up 1 buck so we shall see today. Pete seemed very relaxed and did a wonderful job on camera, however he upset 1/2 of ?Georgia by throwing UGA under the bus with his allegiance to GA Tech.
Doc actually buys amniofix for his practice and has seen it work first hand. You can't blame him for cheerleading as he knows the potential not only as an investor, but a Doctor on our board who has put his money where his mouth is.
Listening to Jeffries conference and Bill Taylor just stated they are focusing on International expansion and expect meaningful revenue growth starting in 2016
Rentdmc ,,,the hardest part in investing is waiting, the greatest gains in life can be had by doing what is hard.
Story is unfolding, have faith and patience. I have been here over 5.5 years, and yes, the waiting is difficult.
The fact that injectable is attributing 15 percent of sales with zero marketing and zero mentions in any conference setting is telling. Of course Mdxg can't mention injectables because that is the reason for the untitled letter and knowing the Liberal biased FDA they would find any excuse to send a warning letter out to right wing Pete. This time last year stock was basing near 7, 10 is the new 7. Story is playing out, relax, buy more and enjoy the ride to the buyout.
I wouldn't think the management would want to go into a shareholder meeting with the stock much lower. Would be a good time for a 10 million dollar buy back at 10:59am Thursday morning. :)))
With 17 million short they are holding a nuclear bomb in their hands, at any time we could receive a favorable transition letter for injectable, or we could receive a buyout from 2 to 4 billion. If we were debt ridden, had unseasoned management and a product that had declining sales I could understand the short story. With that said there are plenty of shorts who have been short apple for 4 years, ouch. Mdxg is generating tons of cash, Pete has forecasted 20 percent returns of net profit and ,that cash is going to have to used for something beside hiring more sales people at some near point in the future.
Cicero, it is painfully clear that management is needing to be quiet on the injectable for a reason. As painful as it is to wallow around on light volume don't forget we are up 900 percent from 3 years ago and up over 40 percent give or take from this time last year. I am confident we will arrive at our destination, the journey will be paved with some doubt and fear. With the blanket thrown over this stock because of the liberal agenda of the FDa our gains will probably come in quick bursts . Until then, think of the pain of those who bought at 9 10 and 11, it must be unbearable, which in all of my years of trading unbearable pain in a great company usually results in unbelievable gains. After 5 years of holding I am expecting a short squeeze of all squeezes if the FDA news regarding injectable is favorable. Until the , have comfort with exploding sales, no debt and yes the injectable is a disrupter that will be known by the world soon. My "heart" tells me so, pun intended:)))